NCT00788307View on ClinicalTrials.gov

Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External-Beam Radiation Therapy

PHASE1TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 3, 2008

Primary Completion Date

February 7, 2018

Study Completion Date

February 7, 2018

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

Ad5-CMV-NIS

DRUG

liothyronine sodium

GENETIC

reverse transcriptase-polymerase chain reaction

OTHER

laboratory biomarker analysis

RADIATION

iodine I 131

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER